ATLANTA, GA - July 16, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer, today ...
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...
2025 AUG 04 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Daily-- Fresh data on Immune System Diseases and Conditions - HIV/AIDS are presented in a new report. According to news ...
SHELTON, CT / ACCESS Newswire / July 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...
Researchers report undetected mpox exposure in Nigeria, highlighting blind spots in symptom-based disease surveillance.
NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”. These agents mimic cell surface ...
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc. (NNVC), a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results